AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $154,000 | +294.9% | 486,568 | +794.9% | 0.02% | +300.0% |
| Q1 2022 | $39,000 | -94.7% | 54,370 | -78.6% | 0.01% | -93.3% |
| Q3 2021 | $733,000 | +103.6% | 254,376 | +97.8% | 0.08% | +27.1% |
| Q4 2020 | $360,000 | +60.0% | 128,626 | +43.5% | 0.06% | +55.3% |
| Q3 2020 | $225,000 | +118.4% | 89,663 | +242.4% | 0.04% | +171.4% |
| Q3 2019 | $103,000 | +5.1% | 26,187 | +140.7% | 0.01% | +133.3% |
| Q1 2016 | $98,000 | – | 10,881 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |